| Symbol | MDCOY |
|---|---|
| Name | PT MEDCO ENERGI INTERNASIONAL TBK |
| Sector | UNDEFINED |
| Region | Asia |
| Industry | - |
| Address | 12190 Indonesia The Energy 53nd Fl. SCBD Lot 11A |
| Telephone | +62 21 29953000 |
| Fax | — |
| — | |
| Website | http://www.medcoenergi.com |
| Incorporation | ID |
| Incorporated On | 1980 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | KAP Purwanto, Susanti & Surja; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Indonesia Stock Exchange |
| CIK | 0002094100 |
| Description | PT Medco Energi Internasional Tbk (ticker: MEDC-IDX) is a premier energy and natural resources company in Southeast Asia with diversified operations across three business segments: Oil & Gas, Clean Power, and Copper & Gold Mining. The company operates across Southeast Asia and the Middle East, with a significant presence in Indonesia and operations in Oman, Thailand, and Yemen. Founded in 1980 as Indonesias first indigenous drilling contractor, MedcoEnergi evolved into an Exploration & Production company in 1992 and conducted its IPO on the Indonesia Stock Exchange in 1994. Strategic milestones include the 1996 discovery of the Kaji and Semoga fields, expansion into renewable energy through the Sarulla geothermal project in 2013, and the 2019 acquisition of Ophir Energy plc. The Oil & Gas segment operates 26 assets across Indonesia and internationally, with key producing assets including the Corridor Block in South Sumatra and the South Natuna Sea Block B PSC. Through Medco Power Indonesia, the company operates gas, solar, geothermal, and hydro Independent Power Plants. MedcoEnergi holds a significant minority interest in PT Amman Mineral Internasional Tbk, which operates the Batu Hijau copper-gold mine, Indonesias second-largest. MedcoEnergi maintains investment-grade trajectory credit ratings, demonstrates commitment to shareholder returns through progressive dividends and buybacks, and targets net-zero Scope 1 and 2 emissions by 2050. Additional info from OTC: Additional info from OTC: |
No news found.